David Sabbagh, MD
Family Medicine · Port Huron, MINPI 1295183747
Payments from drug & device makers
Across 260 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$682
- Novo Nordisk$390
- Amgen$371
- Otsuka America Pharmaceutical, Inc.$315
- Vanda Pharmaceuticals Inc.$294
- Radius Health, Inc.$252
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,292100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 55 | $682 |
| Novo Nordisk | 26 | $390 |
| Amgen | 25 | $371 |
| Otsuka America Pharmaceutical, Inc. | 17 | $315 |
| Vanda Pharmaceuticals Inc. | 14 | $294 |
| Radius Health, Inc. | 7 | $252 |
| Alkermes, Inc. | 15 | $236 |
| Lilly USA, LLC | 15 | $235 |
| Novartis | 9 | $157 |
| AstraZeneca | 10 | $156 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $153 |
| Axsome Therapeutics, Inc. | 5 | $119 |
| GSK | 7 | $113 |
| Bayer | 5 | $100 |
| Lundbeck LLC | 5 | $95 |
| Pfizer | 5 | $91 |
| Boehringer Ingelheim | 3 | $77 |
| Johnson & Johnson | 4 | $60 |
| Exact Sciences | 3 | $58 |
| Paratek Pharmaceuticals, Inc. | 3 | $51 |
| Noven Therapeutics, LLC | 2 | $41 |
| Abbott | 2 | $36 |
| Bardy Diagnostics, Inc. | 2 | $36 |
| Astellas Pharma US Inc | 2 | $31 |
| Mylan Specialty L.p. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Medtronic | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
How this compares
$4,292 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 126 | $193,187 |
| EliquisApixaban | 100 | $118,079 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 14 | $106,837 |
| OzempicSemaglutide | 73 | $82,220 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $44,818 |
| Nurtec OdtRimegepant Sulfate | 21 | $38,900 |
| XareltoRivaroxaban | 29 | $37,512 |
| FarxigaDapagliflozin Propanediol | 26 | $33,485 |
| RexultiBrexpiprazole | 15 | $32,045 |
| JardianceEmpagliflozin | 24 | $25,000 |
| JanuviaSitagliptin Phosphate | 14 | $22,126 |
| TrulicityDulaglutide | 12 | $21,303 |
| Repatha SureclickEvolocumab | 13 | $17,435 |
| TrintellixVortioxetine Hydrobromide | 20 | $15,768 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $12,177 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $235 | $214,490138 claims |
| PfizerEliquis, Nurtec Odt | $91 | $156,979121 claims |
| Novo NordiskOzempic | $390 | $82,22073 claims |
| GSKTrelegy Ellipta | $113 | $44,81835 claims |
| Johnson & JohnsonXarelto | $60 | $37,51229 claims |
| AstraZenecaFarxiga | $156 | $33,48526 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $315 | $32,04515 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $77 | $31,85338 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $12 | $15,76820 claims |
| Astellas Pharma US IncMyrbetriq | $31 | $9,29915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Port Huron
- Pietro CavataioPort Huron$40K
- Michele RaymondPort Huron$24K
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
- Loren ChudlerSouthfield$1.3M
- Solomon AmsterWhite Lake$981K
- Matt RosenbergJackson$559K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.